Skip to Content

93 B9 (Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual) 2 mg (base) / 0.5 mg (base))

Pill with imprint 93 B9 is White, Capsule-shape and has been identified as Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual) 2 mg (base) / 0.5 mg (base). It is supplied by Teva Pharmaceuticals USA Inc..

Buprenorphine/naloxone is used in the treatment of opiate dependence and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Buprenorphine/naloxone 2 mg (base) / 0.5 mg (base) is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).

Images for 93 B9

Buprenorphine hydrochloride and naloxone hydrochloride (sublingual) 2 mg (base) / 0.5 mg (base) 93 B9

Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual)

Imprint:
93 B9
Strength:
2 mg (base) / 0.5 mg (base)
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Narcotic analgesic combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
3 - Moderate abuse potential
Labeler / Supplier:
Teva Pharmaceuticals USA Inc.
National Drug Code (NDC):
00093-5720

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide